Related Experiment Video
Updated: Jul 5, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus
Stephane Legriel1, Fabrice Bruneel, Odile Spreux-Varoquaux
1Service de Réanimation Polyvalente, Hôpital André Mignot, 78157, Le Chesnay, France. stlegriel@invivo.edu
Introduction:
Posterior reversible encephalopathy syndrome (PRES) is known to occur in association with several substances. However, lysergic acid amide (LSA) is not among the previously reported causes of PRES.
Methods:
We report on a patient with PRES presenting as convulsive status epilepticus associated with hypertensive encephalopathy after LSA ingestion. Magnetic resonance imaging was performed and catecholamine metabolites assayed.
Results:
The patient achieved a full recovery after aggressive antihypertensive therapy and intravenous anticonvulsivant therapy. The clinical history, blood and urinary catecholamine levels, and response to treatment strongly suggest that PRES was induced by LSA.
Conclusion:
LSA, a hallucinogenic agent chiefly used for recreational purposes, should be added to the list of causes of PRES.
Related Concept Videos
Seizures l: Introduction
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Hepatic Encephalopathy
Encephalitis l: Introduction
